Qiagen

Yahoo Finance • 21 days ago

Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. Non-Invasive Prena... Full story

Yahoo Finance • 24 days ago

U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (Flow Cytometry, PCR, NGS), By Cancer Type (Hematological Malignancy, Solid Tumors), By End Us... Full story

Yahoo Finance • 2 months ago

Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays

Qiagen N.V. (NYSE:QGEN) ranks among the best CRISPR stocks to buy. Qiagen N.V. (NYSE:QGEN) and Gencurix announced a collaboration on June 18 to provide oncology assays for Qiagen’s QIAcuityDx digital PCR platform.Qiagen Teams With Gencurix... Full story

Yahoo Finance • 2 months ago

Qiagen and Gencurix partner on oncology diagnostic assays

VENLO, Netherlands - QIAGEN (NYSE: QGEN), a $10 billion molecular diagnostics company with excellent financial health according to InvestingPro analysis, and GENCURIX (KOSDAQ: 229000) announced a partnership to develop oncology assays for... Full story

Yahoo Finance • 3 months ago

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

On Friday, Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to expand the availability of digital polymerase chain reaction (dPCR) assays for oncology research appli... Full story

Yahoo Finance • 5 months ago

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

VENLO, Netherlands, March 31, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the... Full story

Yahoo Finance • 6 months ago

QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region

New facility reflects QIAGEN’s commitment to enhancing its bioinformatics data center infrastructure in the Australia, New Zealand, New Guinea and surrounding islands region New data center in Melbourne meets Australian regulations to ens... Full story

Yahoo Finance • 6 months ago

Qiagen: Q4 Earnings Snapshot

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported fourth-quarter net income of $88.3 million. On a per-share basis, the Pl Venlo, Netherlands-based company said it had profit of 39 cents. Ear... Full story

Yahoo Finance • last year

QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system

QIAstat-Dx Analyzer 2.0 with Software 1.6 release enables mobile access to test results, streamlining diagnostic processes and enhancing patient care // QIAstat-Dx Analyzer 2.0 also offers enhanced epidemiology dashboards and improved remo... Full story

Yahoo Finance • 2 years ago

Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript

Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript February 11, 2024 Qiagen N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. I'm Melinda, you... Full story

Yahoo Finance • 2 years ago

The Qiagen N.V. (NYSE:QGEN) Full-Year Results Are Out And Analysts Have Published New Forecasts

Last week saw the newest yearly earnings release from Qiagen N.V. (NYSE:QGEN), an important milestone in the company's journey to build a stronger business. Revenues of US$2.0b were in line with forecasts, although statutory earnings per s... Full story

Yahoo Finance • 2 years ago

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S. // U.S. regulatory clearance of new assay for use on both NeuMoDx 96 and 288 versions of integr... Full story

Yahoo Finance • 2 years ago

QIAGEN expands business in Middle East with new regional headquarters and major projects

QIAGEN to open regional headquarters in Riyadh, Saudi Arabia, at the beginning of 2024 to support growing presence in the region // QIAGEN signed Memorandum of Understanding with the Ministry of Health of Saudi Arabia to support public hea... Full story

Yahoo Finance • 2 years ago

QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System

Venlo, the Netherlands, and San Diego, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic partnership to offer comprehensive next-gen... Full story

Yahoo Finance • 2 years ago

Partnerschaft zwischen QIAGEN und Element Biosciences ermöglicht vollständige NGS-Workflows für das AVITI-System

Partnerschaft unterstützt Nutzer des AVITI-Systems von Element bei der Genomanalyse mit QIAseq Panels, CLC LightSpeed und QCI Interpret von QIAGEN // Zusammenarbeit beschleunigt wissenschaftliche Entdeckungen bei Genomanwendungen, macht si... Full story

Yahoo Finance • 2 years ago

QIAGEN und Myriad Genetics schließen Partnerschaft und treiben Entwicklung von Begleitdiagnostika für Krebs voran

Partnerschaft umfasst die Entwicklung von im Labor entwickelten (LDT) und vertriebsfähigen diagnostischen Begleittests auf Kit-Basis // Vereinte Stärken in den Bereichen Assay-Entwicklung, klinische Tests und regulatorische Zulassungen bie... Full story

Yahoo Finance • 2 years ago

QIAGEN N.V. to release results for Q3 2023 and hold webcast

Venlo, the Netherlands, Oct. 09, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter 2023. Press release date / time: Monday, October 30, shortly... Full story

Yahoo Finance • 2 years ago

QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes

Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Sen... Full story

Yahoo Finance • 2 years ago

Nationales Genomzentrum Dänemark entscheidet sich für QIAGEN-Lösung zur Genomsequenzierung in der Onkologie

Als eines der ersten Länder führt Dänemark die Gesamtgenomsequenzierung als Therapiestandard bei onkologischen Erkrankungen ein und nutzt QCI Interpret für nationale Initiative // QCI Interpret soll zur evidenzbasierten Interpretation und... Full story

Yahoo Finance • 2 years ago

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing

Venlo, the Netherlands, and Redwood City, California, June 13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its variant interpretation and reporting software, QIAGEN Clinical Insight (Q... Full story